Oncology

Digital health systems that allow patients to self-report toxicities related to cancer therapies can be successfully adapted to screen for COVID-19, Belgian researchers report.

US researchers have developed the Cancer and Aging Research Group–Breast Cancer score to help predict grade 3–5 chemotherapy-related toxicities in older patients with early-stage breast cancer.

Genomic alterations in CDKN2A are associated with worse clinical outcomes in patients with advanced urothelial carcinoma treated with immune checkpoint inhibitors, report US researchers.

A survey of patients attending four French cancer centers shows that over half are willing to be vaccinated against COVID-19.

Researchers report a marked decrease in the number of oncology clinical trials launched during the COVID-19 pandemic compared with the prepandemic period.

Black women with breast cancer are more likely than non-Hispanic White women to have a high-risk 21-gene Oncotype DX Breast Recurrence Score, and are more likely to die of breast cancer than their non-Hispanic White counterparts with a comparable score, US research shows.